Rankings
▼
Calendar
VRDN Q4 2016 Earnings — Viridian Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
VRDN
Viridian Therapeutics, Inc.
$2B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$756,000
Gross Profit
$64,000
8.5% margin
Operating Income
-$5M
-723.9% margin
Net Income
-$6M
-736.8% margin
EPS (Diluted)
$-7.23
QoQ Revenue Growth
-15.0%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$670,000
Balance Sheet
Total Assets
$4M
Total Liabilities
$5M
Stockholders' Equity
-$326,000
Cash & Equivalents
$3M
← FY 2016
All Quarters
Q1 2017 →
